Iovance Biotherapeutics
Tarik Messaoud is a Medical Director at Iovance Biotherapeutics, Inc. with experience in drug safety related to T-Cell Therapy and Tumor Infiltrating Lymphocytes. Prior to their current role, Tarik worked as a Drug Safety Physician at Merck, focusing on Check Point Inhibitor pembrolizumab. With a background in medicine and management, Tarik has also held positions as a Medical Science Liaison at GlaxoSmithKline and as a Clinical Research Project Manager in the hospital and healthcare sector.
This person is not in any teams
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.